Sun Yidan, Xu Luwen, Li Yin, Lin Jian, Li Haizhou, Gao Yashan, Huang Xiaolu, Zhu Hainan, Zhang Yingfan, Wei Kunchen, Yang Yali, Wu Baojin, Zhang Liang, Li Qingfeng, Liu Caiyue
Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Front Cell Dev Biol. 2022 May 30;10:865983. doi: 10.3389/fcell.2022.865983. eCollection 2022.
Tissue expansion is a commonly performed therapy to grow extra skin for reconstruction. While mechanical stretch-induced epidermal changes have been extensively studied in rodents and cell culture, little is known about the mechanobiology of the human epidermis . Here, we employed single-cell RNA sequencing to interrogate the changes in the human epidermis during long-term tissue expansion therapy in clinical settings. We also verified the main findings at the protein level by immunofluorescence analysis of independent clinical samples. Our data show that the expanding human skin epidermis maintained a cellular composition and lineage trajectory that are similar to its non-expanding neighbor, suggesting the cellular heterogeneity of long-term expanded samples differs from the early response to the expansion. Also, a decrease in proliferative cells due to the decayed regenerative competency was detected. On the other hand, profound transcriptional changes are detected for epidermal stem cells in the expanding skin versus their non-expanding peers. These include significantly enriched signatures of C-FOS, EMT, and mTOR pathways and upregulation of AREG and SERPINB2 genes. CellChat associated ligand-receptor pairs and signaling pathways were revealed. Together, our data present a single-cell atlas of human epidermal changes in long-term tissue expansion therapy, suggesting that transcriptional change in epidermal stem cells is the major mechanism underlying long-term human skin expansion therapy. We also identified novel therapeutic targets to promote human skin expansion efficiency in the future.
组织扩张是一种常用的治疗方法,用于生长额外的皮肤以进行重建。虽然机械拉伸诱导的表皮变化已在啮齿动物和细胞培养中得到广泛研究,但对于人类表皮的机械生物学却知之甚少。在这里,我们采用单细胞RNA测序来探究临床环境中长期组织扩张治疗期间人类表皮的变化。我们还通过对独立临床样本的免疫荧光分析在蛋白质水平上验证了主要发现。我们的数据表明,正在扩张的人类皮肤表皮维持了与其未扩张的相邻组织相似的细胞组成和谱系轨迹,这表明长期扩张样本的细胞异质性不同于对扩张的早期反应。此外,还检测到由于再生能力衰退导致的增殖细胞减少。另一方面,与未扩张的表皮干细胞相比,正在扩张的皮肤中的表皮干细胞检测到了深刻的转录变化。这些变化包括C-FOS、EMT和mTOR通路的显著富集特征以及AREG和SERPINB2基因的上调。揭示了CellChat相关的配体-受体对和信号通路。总之,我们的数据展示了长期组织扩张治疗中人类表皮变化的单细胞图谱,表明表皮干细胞的转录变化是长期人类皮肤扩张治疗的主要机制。我们还确定了未来促进人类皮肤扩张效率的新治疗靶点。